Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study
Table 5
Comparison between different models of ROC analysis.
Models
values
Linolelaidic Acid (C18:2N6T)_Combine
0.0065
L-Dihydroorotic Acid_Combine
0.00194
Azoxystrobin Acid_Combine
0.0076
L-Dihydroorotic Acid_Linolelaidic Acid (C18:2N6T)
0.8192
Azoxystrobin Acid_Linolelaidic Acid (C18:2N6T)
0.8194
Azoxystrobin Acid_L-Dihydroorotic Acid
0.6862
Linolelaidic Acid (C18:2N6T)_combine1
0.0886
L-Dihydroorotic Acid_combine1
0.13
Azoxystrobin Acid_combine1
0.0502
The model of Combine 1 contains Linolelaidic Acid (C18:2N6T), L-Dihydroorotic Acid, and Azoxystrobin Acid; the model of Combine contains 11 metabolites. Chi-square test was utilized to compare the differences.
